Global Typhoid Fever Vaccines Market Growth 2025-2031

December 2025 | 92 pages | ID: G369CD781A5EN
LP Information

Abstracts

The global Typhoid Fever Vaccines market size is predicted to grow from US$ 250 million in 2025 to US$ 342 million in 2031; it is expected to grow at a CAGR of 5.4% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Typhoid fever is contracted by drinking or eating the Salmonella bacteria in contaminated food or water. Typhoid Fever Vaccines prevent typhoid fever and provide protection against it.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LP Information, Inc. (LPI) ' newest research report, the “Typhoid Fever Vaccines Industry Forecast” looks at past sales and reviews total world Typhoid Fever Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Typhoid Fever Vaccines sales for 2025 through 2031. With Typhoid Fever Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Typhoid Fever Vaccines industry.

This Insight Report provides a comprehensive analysis of the global Typhoid Fever Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Typhoid Fever Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Typhoid Fever Vaccines market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Typhoid Fever Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Typhoid Fever Vaccines.

This report presents a comprehensive overview, market shares, and growth opportunities of Typhoid Fever Vaccines market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Live Attenuated Vaccine
• Conjugate Vaccine
• Capsular Polysaccharide Vaccines
• Others

Segmentation by Application:

• Government Institution
• Private Sector

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Sanofi Pasteur
• GlaxoSmithKline
• Bharat Biotech
• PaxVax
• Biomed
• Prokarium
• China National Biotec Group

Key Questions Addressed in this Report

What is the 10-year outlook for the global Typhoid Fever Vaccines market?

What factors are driving Typhoid Fever Vaccines market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Typhoid Fever Vaccines market opportunities vary by end market size?

How does Typhoid Fever Vaccines break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Typhoid Fever Vaccines Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Typhoid Fever Vaccines by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Typhoid Fever Vaccines by Country/Region, 2020, 2024 & 2031
2.2 Typhoid Fever Vaccines Segment by Type
  2.2.1 Live Attenuated Vaccine
  2.2.2 Conjugate Vaccine
  2.2.3 Capsular Polysaccharide Vaccines
  2.2.4 Others
2.3 Typhoid Fever Vaccines Sales by Type
  2.3.1 Global Typhoid Fever Vaccines Sales Market Share by Type (2020-2025)
  2.3.2 Global Typhoid Fever Vaccines Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Typhoid Fever Vaccines Sale Price by Type (2020-2025)
2.4 Typhoid Fever Vaccines Segment by Application
  2.4.1 Government Institution
  2.4.2 Private Sector
2.5 Typhoid Fever Vaccines Sales by Application
  2.5.1 Global Typhoid Fever Vaccines Sale Market Share by Application (2020-2025)
  2.5.2 Global Typhoid Fever Vaccines Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Typhoid Fever Vaccines Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Typhoid Fever Vaccines Breakdown Data by Company
  3.1.1 Global Typhoid Fever Vaccines Annual Sales by Company (2020-2025)
  3.1.2 Global Typhoid Fever Vaccines Sales Market Share by Company (2020-2025)
3.2 Global Typhoid Fever Vaccines Annual Revenue by Company (2020-2025)
  3.2.1 Global Typhoid Fever Vaccines Revenue by Company (2020-2025)
  3.2.2 Global Typhoid Fever Vaccines Revenue Market Share by Company (2020-2025)
3.3 Global Typhoid Fever Vaccines Sale Price by Company
3.4 Key Manufacturers Typhoid Fever Vaccines Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Typhoid Fever Vaccines Product Location Distribution
  3.4.2 Players Typhoid Fever Vaccines Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR TYPHOID FEVER VACCINES BY GEOGRAPHIC REGION

4.1 World Historic Typhoid Fever Vaccines Market Size by Geographic Region (2020-2025)
  4.1.1 Global Typhoid Fever Vaccines Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Typhoid Fever Vaccines Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Typhoid Fever Vaccines Market Size by Country/Region (2020-2025)
  4.2.1 Global Typhoid Fever Vaccines Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Typhoid Fever Vaccines Annual Revenue by Country/Region (2020-2025)
4.3 Americas Typhoid Fever Vaccines Sales Growth
4.4 APAC Typhoid Fever Vaccines Sales Growth
4.5 Europe Typhoid Fever Vaccines Sales Growth
4.6 Middle East & Africa Typhoid Fever Vaccines Sales Growth

5 AMERICAS

5.1 Americas Typhoid Fever Vaccines Sales by Country
  5.1.1 Americas Typhoid Fever Vaccines Sales by Country (2020-2025)
  5.1.2 Americas Typhoid Fever Vaccines Revenue by Country (2020-2025)
5.2 Americas Typhoid Fever Vaccines Sales by Type (2020-2025)
5.3 Americas Typhoid Fever Vaccines Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Typhoid Fever Vaccines Sales by Region
  6.1.1 APAC Typhoid Fever Vaccines Sales by Region (2020-2025)
  6.1.2 APAC Typhoid Fever Vaccines Revenue by Region (2020-2025)
6.2 APAC Typhoid Fever Vaccines Sales by Type (2020-2025)
6.3 APAC Typhoid Fever Vaccines Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Typhoid Fever Vaccines by Country
  7.1.1 Europe Typhoid Fever Vaccines Sales by Country (2020-2025)
  7.1.2 Europe Typhoid Fever Vaccines Revenue by Country (2020-2025)
7.2 Europe Typhoid Fever Vaccines Sales by Type (2020-2025)
7.3 Europe Typhoid Fever Vaccines Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Typhoid Fever Vaccines by Country
  8.1.1 Middle East & Africa Typhoid Fever Vaccines Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Typhoid Fever Vaccines Revenue by Country (2020-2025)
8.2 Middle East & Africa Typhoid Fever Vaccines Sales by Type (2020-2025)
8.3 Middle East & Africa Typhoid Fever Vaccines Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Typhoid Fever Vaccines
10.3 Manufacturing Process Analysis of Typhoid Fever Vaccines
10.4 Industry Chain Structure of Typhoid Fever Vaccines

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Typhoid Fever Vaccines Distributors
11.3 Typhoid Fever Vaccines Customer

12 WORLD FORECAST REVIEW FOR TYPHOID FEVER VACCINES BY GEOGRAPHIC REGION

12.1 Global Typhoid Fever Vaccines Market Size Forecast by Region
  12.1.1 Global Typhoid Fever Vaccines Forecast by Region (2026-2031)
  12.1.2 Global Typhoid Fever Vaccines Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Typhoid Fever Vaccines Forecast by Type (2026-2031)
12.7 Global Typhoid Fever Vaccines Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Sanofi Pasteur
  13.1.1 Sanofi Pasteur Company Information
  13.1.2 Sanofi Pasteur Typhoid Fever Vaccines Product Portfolios and Specifications
  13.1.3 Sanofi Pasteur Typhoid Fever Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Sanofi Pasteur Main Business Overview
  13.1.5 Sanofi Pasteur Latest Developments
13.2 GlaxoSmithKline
  13.2.1 GlaxoSmithKline Company Information
  13.2.2 GlaxoSmithKline Typhoid Fever Vaccines Product Portfolios and Specifications
  13.2.3 GlaxoSmithKline Typhoid Fever Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 GlaxoSmithKline Main Business Overview
  13.2.5 GlaxoSmithKline Latest Developments
13.3 Bharat Biotech
  13.3.1 Bharat Biotech Company Information
  13.3.2 Bharat Biotech Typhoid Fever Vaccines Product Portfolios and Specifications
  13.3.3 Bharat Biotech Typhoid Fever Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Bharat Biotech Main Business Overview
  13.3.5 Bharat Biotech Latest Developments
13.4 PaxVax
  13.4.1 PaxVax Company Information
  13.4.2 PaxVax Typhoid Fever Vaccines Product Portfolios and Specifications
  13.4.3 PaxVax Typhoid Fever Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 PaxVax Main Business Overview
  13.4.5 PaxVax Latest Developments
13.5 Biomed
  13.5.1 Biomed Company Information
  13.5.2 Biomed Typhoid Fever Vaccines Product Portfolios and Specifications
  13.5.3 Biomed Typhoid Fever Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Biomed Main Business Overview
  13.5.5 Biomed Latest Developments
13.6 Prokarium
  13.6.1 Prokarium Company Information
  13.6.2 Prokarium Typhoid Fever Vaccines Product Portfolios and Specifications
  13.6.3 Prokarium Typhoid Fever Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Prokarium Main Business Overview
  13.6.5 Prokarium Latest Developments
13.7 China National Biotec Group
  13.7.1 China National Biotec Group Company Information
  13.7.2 China National Biotec Group Typhoid Fever Vaccines Product Portfolios and Specifications
  13.7.3 China National Biotec Group Typhoid Fever Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 China National Biotec Group Main Business Overview
  13.7.5 China National Biotec Group Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Typhoid Fever Vaccines Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Typhoid Fever Vaccines Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Live Attenuated Vaccine
Table 4. Major Players of Conjugate Vaccine
Table 5. Major Players of Capsular Polysaccharide Vaccines
Table 6. Major Players of Others
Table 7. Global Typhoid Fever Vaccines Sales by Type (2020-2025) & (K Doses)
Table 8. Global Typhoid Fever Vaccines Sales Market Share by Type (2020-2025)
Table 9. Global Typhoid Fever Vaccines Revenue by Type (2020-2025) & ($ million)
Table 10. Global Typhoid Fever Vaccines Revenue Market Share by Type (2020-2025)
Table 11. Global Typhoid Fever Vaccines Sale Price by Type (2020-2025) & (USD/Dose)
Table 12. Global Typhoid Fever Vaccines Sale by Application (2020-2025) & (K Doses)
Table 13. Global Typhoid Fever Vaccines Sale Market Share by Application (2020-2025)
Table 14. Global Typhoid Fever Vaccines Revenue by Application (2020-2025) & ($ million)
Table 15. Global Typhoid Fever Vaccines Revenue Market Share by Application (2020-2025)
Table 16. Global Typhoid Fever Vaccines Sale Price by Application (2020-2025) & (USD/Dose)
Table 17. Global Typhoid Fever Vaccines Sales by Company (2020-2025) & (K Doses)
Table 18. Global Typhoid Fever Vaccines Sales Market Share by Company (2020-2025)
Table 19. Global Typhoid Fever Vaccines Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Typhoid Fever Vaccines Revenue Market Share by Company (2020-2025)
Table 21. Global Typhoid Fever Vaccines Sale Price by Company (2020-2025) & (USD/Dose)
Table 22. Key Manufacturers Typhoid Fever Vaccines Producing Area Distribution and Sales Area
Table 23. Players Typhoid Fever Vaccines Products Offered
Table 24. Typhoid Fever Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Typhoid Fever Vaccines Sales by Geographic Region (2020-2025) & (K Doses)
Table 28. Global Typhoid Fever Vaccines Sales Market Share Geographic Region (2020-2025)
Table 29. Global Typhoid Fever Vaccines Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Typhoid Fever Vaccines Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Typhoid Fever Vaccines Sales by Country/Region (2020-2025) & (K Doses)
Table 32. Global Typhoid Fever Vaccines Sales Market Share by Country/Region (2020-2025)
Table 33. Global Typhoid Fever Vaccines Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Typhoid Fever Vaccines Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Typhoid Fever Vaccines Sales by Country (2020-2025) & (K Doses)
Table 36. Americas Typhoid Fever Vaccines Sales Market Share by Country (2020-2025)
Table 37. Americas Typhoid Fever Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Typhoid Fever Vaccines Sales by Type (2020-2025) & (K Doses)
Table 39. Americas Typhoid Fever Vaccines Sales by Application (2020-2025) & (K Doses)
Table 40. APAC Typhoid Fever Vaccines Sales by Region (2020-2025) & (K Doses)
Table 41. APAC Typhoid Fever Vaccines Sales Market Share by Region (2020-2025)
Table 42. APAC Typhoid Fever Vaccines Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Typhoid Fever Vaccines Sales by Type (2020-2025) & (K Doses)
Table 44. APAC Typhoid Fever Vaccines Sales by Application (2020-2025) & (K Doses)
Table 45. Europe Typhoid Fever Vaccines Sales by Country (2020-2025) & (K Doses)
Table 46. Europe Typhoid Fever Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Typhoid Fever Vaccines Sales by Type (2020-2025) & (K Doses)
Table 48. Europe Typhoid Fever Vaccines Sales by Application (2020-2025) & (K Doses)
Table 49. Middle East & Africa Typhoid Fever Vaccines Sales by Country (2020-2025) & (K Doses)
Table 50. Middle East & Africa Typhoid Fever Vaccines Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Typhoid Fever Vaccines Sales by Type (2020-2025) & (K Doses)
Table 52. Middle East & Africa Typhoid Fever Vaccines Sales by Application (2020-2025) & (K Doses)
Table 53. Key Market Drivers & Growth Opportunities of Typhoid Fever Vaccines
Table 54. Key Market Challenges & Risks of Typhoid Fever Vaccines
Table 55. Key Industry Trends of Typhoid Fever Vaccines
Table 56. Typhoid Fever Vaccines Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Typhoid Fever Vaccines Distributors List
Table 59. Typhoid Fever Vaccines Customer List
Table 60. Global Typhoid Fever Vaccines Sales Forecast by Region (2026-2031) & (K Doses)
Table 61. Global Typhoid Fever Vaccines Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Typhoid Fever Vaccines Sales Forecast by Country (2026-2031) & (K Doses)
Table 63. Americas Typhoid Fever Vaccines Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Typhoid Fever Vaccines Sales Forecast by Region (2026-2031) & (K Doses)
Table 65. APAC Typhoid Fever Vaccines Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Typhoid Fever Vaccines Sales Forecast by Country (2026-2031) & (K Doses)
Table 67. Europe Typhoid Fever Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Typhoid Fever Vaccines Sales Forecast by Country (2026-2031) & (K Doses)
Table 69. Middle East & Africa Typhoid Fever Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Typhoid Fever Vaccines Sales Forecast by Type (2026-2031) & (K Doses)
Table 71. Global Typhoid Fever Vaccines Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Typhoid Fever Vaccines Sales Forecast by Application (2026-2031) & (K Doses)
Table 73. Global Typhoid Fever Vaccines Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Sanofi Pasteur Basic Information, Typhoid Fever Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 75. Sanofi Pasteur Typhoid Fever Vaccines Product Portfolios and Specifications
Table 76. Sanofi Pasteur Typhoid Fever Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 77. Sanofi Pasteur Main Business
Table 78. Sanofi Pasteur Latest Developments
Table 79. GlaxoSmithKline Basic Information, Typhoid Fever Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 80. GlaxoSmithKline Typhoid Fever Vaccines Product Portfolios and Specifications
Table 81. GlaxoSmithKline Typhoid Fever Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 82. GlaxoSmithKline Main Business
Table 83. GlaxoSmithKline Latest Developments
Table 84. Bharat Biotech Basic Information, Typhoid Fever Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 85. Bharat Biotech Typhoid Fever Vaccines Product Portfolios and Specifications
Table 86. Bharat Biotech Typhoid Fever Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 87. Bharat Biotech Main Business
Table 88. Bharat Biotech Latest Developments
Table 89. PaxVax Basic Information, Typhoid Fever Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 90. PaxVax Typhoid Fever Vaccines Product Portfolios and Specifications
Table 91. PaxVax Typhoid Fever Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 92. PaxVax Main Business
Table 93. PaxVax Latest Developments
Table 94. Biomed Basic Information, Typhoid Fever Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 95. Biomed Typhoid Fever Vaccines Product Portfolios and Specifications
Table 96. Biomed Typhoid Fever Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 97. Biomed Main Business
Table 98. Biomed Latest Developments
Table 99. Prokarium Basic Information, Typhoid Fever Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 100. Prokarium Typhoid Fever Vaccines Product Portfolios and Specifications
Table 101. Prokarium Typhoid Fever Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 102. Prokarium Main Business
Table 103. Prokarium Latest Developments
Table 104. China National Biotec Group Basic Information, Typhoid Fever Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 105. China National Biotec Group Typhoid Fever Vaccines Product Portfolios and Specifications
Table 106. China National Biotec Group Typhoid Fever Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 107. China National Biotec Group Main Business
Table 108. China National Biotec Group Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Typhoid Fever Vaccines
Figure 2. Typhoid Fever Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Typhoid Fever Vaccines Sales Growth Rate 2020-2031 (K Doses)
Figure 7. Global Typhoid Fever Vaccines Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Typhoid Fever Vaccines Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Typhoid Fever Vaccines Sales Market Share by Country/Region (2024)
Figure 10. Typhoid Fever Vaccines Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Live Attenuated Vaccine
Figure 12. Product Picture of Conjugate Vaccine
Figure 13. Product Picture of Capsular Polysaccharide Vaccines
Figure 14. Product Picture of Others
Figure 15. Global Typhoid Fever Vaccines Sales Market Share by Type in 2025
Figure 16. Global Typhoid Fever Vaccines Revenue Market Share by Type (2020-2025)
Figure 17. Typhoid Fever Vaccines Consumed in Government Institution
Figure 18. Global Typhoid Fever Vaccines Market: Government Institution (2020-2025) & (K Doses)
Figure 19. Typhoid Fever Vaccines Consumed in Private Sector
Figure 20. Global Typhoid Fever Vaccines Market: Private Sector (2020-2025) & (K Doses)
Figure 21. Global Typhoid Fever Vaccines Sale Market Share by Application (2024)
Figure 22. Global Typhoid Fever Vaccines Revenue Market Share by Application in 2025
Figure 23. Typhoid Fever Vaccines Sales by Company in 2025 (K Doses)
Figure 24. Global Typhoid Fever Vaccines Sales Market Share by Company in 2025
Figure 25. Typhoid Fever Vaccines Revenue by Company in 2025 ($ millions)
Figure 26. Global Typhoid Fever Vaccines Revenue Market Share by Company in 2025
Figure 27. Global Typhoid Fever Vaccines Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Typhoid Fever Vaccines Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Typhoid Fever Vaccines Sales 2020-2025 (K Doses)
Figure 30. Americas Typhoid Fever Vaccines Revenue 2020-2025 ($ millions)
Figure 31. APAC Typhoid Fever Vaccines Sales 2020-2025 (K Doses)
Figure 32. APAC Typhoid Fever Vaccines Revenue 2020-2025 ($ millions)
Figure 33. Europe Typhoid Fever Vaccines Sales 2020-2025 (K Doses)
Figure 34. Europe Typhoid Fever Vaccines Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Typhoid Fever Vaccines Sales 2020-2025 (K Doses)
Figure 36. Middle East & Africa Typhoid Fever Vaccines Revenue 2020-2025 ($ millions)
Figure 37. Americas Typhoid Fever Vaccines Sales Market Share by Country in 2025
Figure 38. Americas Typhoid Fever Vaccines Revenue Market Share by Country (2020-2025)
Figure 39. Americas Typhoid Fever Vaccines Sales Market Share by Type (2020-2025)
Figure 40. Americas Typhoid Fever Vaccines Sales Market Share by Application (2020-2025)
Figure 41. United States Typhoid Fever Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Typhoid Fever Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Typhoid Fever Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Typhoid Fever Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Typhoid Fever Vaccines Sales Market Share by Region in 2025
Figure 46. APAC Typhoid Fever Vaccines Revenue Market Share by Region (2020-2025)
Figure 47. APAC Typhoid Fever Vaccines Sales Market Share by Type (2020-2025)
Figure 48. APAC Typhoid Fever Vaccines Sales Market Share by Application (2020-2025)
Figure 49. China Typhoid Fever Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Typhoid Fever Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Typhoid Fever Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Typhoid Fever Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 53. India Typhoid Fever Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Typhoid Fever Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Typhoid Fever Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Typhoid Fever Vaccines Sales Market Share by Country in 2025
Figure 57. Europe Typhoid Fever Vaccines Revenue Market Share by Country (2020-2025)
Figure 58. Europe Typhoid Fever Vaccines Sales Market Share by Type (2020-2025)
Figure 59. Europe Typhoid Fever Vaccines Sales Market Share by Application (2020-2025)
Figure 60. Germany Typhoid Fever Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 61. France Typhoid Fever Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Typhoid Fever Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Typhoid Fever Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Typhoid Fever Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Typhoid Fever Vaccines Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Typhoid Fever Vaccines Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Typhoid Fever Vaccines Sales Market Share by Application (2020-2025)
Figure 68. Egypt Typhoid Fever Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Typhoid Fever Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Typhoid Fever Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Typhoid Fever Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Typhoid Fever Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Typhoid Fever Vaccines in 2025
Figure 74. Manufacturing Process Analysis of Typhoid Fever Vaccines
Figure 75. Industry Chain Structure of Typhoid Fever Vaccines
Figure 76. Channels of Distribution
Figure 77. Global Typhoid Fever Vaccines Sales Market Forecast by Region (2026-2031)
Figure 78. Global Typhoid Fever Vaccines Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Typhoid Fever Vaccines Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Typhoid Fever Vaccines Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Typhoid Fever Vaccines Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Typhoid Fever Vaccines Revenue Market Share Forecast by Application (2026-2031)